Dylan T. Jones

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Dylan Jones, Dylan T Jones, Dylan Trefor Jones
Publication record
32 papers · 2,878 citations · H-index 19

PAPERS

Expression Profile of Myoepithelial Cells in DCIS: Do They Change From Protective Angels to Wicked Witches?
20223 citationsauthor #2
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
201817 citationsauthor #1
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments
2016216 citationsauthor #5
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
2015729 citationsauthor #3
Acetyl-coA synthetase 2 promotes acetate utilization and maintains cell growth under metabolic stress
201410 citationsauthor #3
FAK-heterozygous mice display enhanced tumour angiogenesis
201346 citationsauthor #6
Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels
201237 citationsauthor #3
Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions
201218 citationsauthor #1
Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice
201223 citationsauthor #1
Use of the mouse aortic ring assay to study angiogenesis
2011485 citationsauthor #7
Abstract 4848: Genetic profile of invasive breast cancer vasculature using laser capture microdissection (LCM) to capture vessels
20110 citationsauthor #1
Vascular Biology , Atherosclerosis and Endothelium Biology Endothelial 3 1-Integrin Represses Pathological Angiogenesis and Sustains Endothelial-VEGF
201061 citationsauthor #11
Microenvironmental Changes in DCIS: Myoepithelial Cells Change from Tumour Suppressor to Tumour Promoter.
20090 citationsauthor #2
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
2009486 citationsauthor #11
Regulation of lymphatic-blood vessel separation by endothelial Rac1
200941 citationsauthor #2
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding
200658 citationsauthor #1
Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
200669 citationsauthor #1
NovelThioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-A Expression but Decrease Functional Transcriptional Activity , DNABinding , and Degradation
20061 citationsauthor #1
Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-α Expression but Decrease Functional Transcriptional Activity, DNA Binding, and Degradation
200657 citationsauthor #1
Synergistic inhibition of tumour cell proliferation and upregulation of Hif-1 alpha using two anti-transferrin receptor antibodies.
20040 citationsauthor #1
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
2004102 citationsauthor #4
The Sesquiterpene Lactone Parthenolide Rapidly and Selectively Induces Apoptosis of B-Chronic Lymphocytic Leukemia Cells.
20040 citationsauthor #6
Geldanamycin and Herbimycin A induce apoptotic killing of B-chronic lymphocytic leukemia cells and augment their sensitivity to cytotoxic drugs Short Title: Geldanamycin actions on CLL cells
20030 citationsauthor #1
leukemia cells and augment their sensitivity to cytotoxic Geldanamycin and Herbimycin A induce apoptotic killing of B-chronic
20030 citationsauthor #1
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
200388 citationsauthor #1
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor‐related apoptosis‐inducing ligand
200330 citationsauthor #1
The role of death receptor, litigation and signal transduction inhibition in the killing of leukaemia cells by cytotoxic drugs and radiation.
20020 citationsauthor #1
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
200267 citationsauthor #3
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.
200244 citationsauthor #4
Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage‐induced apoptosis in B‐chronic lymphocytic leukaemia cells
200145 citationsauthor #3
ARF1 Mediates Paxillin Recruitment to Focal Adhesions and Potentiates Rho-stimulated Stress Fiber Formation in Intact and Permeabilized Swiss 3T3 Fibroblasts
1998149 citationsauthor #2
ERa directly regulates the hypoxia-inducible factor 1 pathway associated with anti-estrogen response in breast cancer
year unknown0 citationsauthor #3

TIMELINE

1998 149 citations

2001 45 citations

2002 111 citations

2003 118 citations

2004 102 citations

2006 185 citations

2009 527 citations

2010 61 citations

2011 485 citations

2012 78 citations

2013 46 citations

2014 10 citations

2015 729 citations

2016 216 citations

2018 17 citations

2022 3 citations

Unknown 0 citations

Dylan T. Jones

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT